{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-008618","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2025-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.050926+00:00","generated_at":"2026-05-16T17:38:22.927425+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"low","headline":"Actuate Therapeutics lists official disclosure channels including social media","bullets":["Company announced it will use website, press releases, SEC filings, and social media for material information.","Social media channels include X (@ActuateThera), LinkedIn, and Facebook.","Investors can subscribe to press releases and SEC filings on the company's investor relations page.","List may be updated from time to time; no other material news disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-008618","json":"https://secwatch.observer/filing/0001683168-25-008618.json","markdown":"https://secwatch.observer/filing/0001683168-25-008618.md","text":"https://secwatch.observer/filing/0001683168-25-008618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825008618/0001683168-25-008618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825008618/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:38:22.927425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}